Zacks Investment Research on MSN2d
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst
Milestone Pharmaceuticals MIST recently announced that the FDA has issued a Complete Response Letter (“CRL”) for its New Drug ...
Yahoo Finance15d
Milestone Pharmaceuticals Inc. (MIST)
TD Cowen downgraded Milestone Pharmaceuticals (MIST) to Hold from Buy and suspended the firm’s price target after Milestone announced the FDA issued a Complete Response Letter regarding its New ...